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Relationship of serum leptin with 
parameters of nutritional status and 
body composition among patients with 
stable course of cardiovascular 
disorders
AbstRAct 
Background: Blood leptin concentration is related to fat mass, adipose cell and leptin receptor function, and 
comorbidities. The aim of this study is to determine the relationships between blood leptin concentration 
and nutritional status assessment among inpatients with stable cardiovascular disorders. 
Materials and Methods: Blood leptin concentration and nutritional risk and status assessments using clinical, 
anthropometric and biochemical parameters, as well bioelectrical impedance (BIA), were determined in 
160 consecutive inpatients with mild exacerbation of cardiovascular diseases cardiovascular disorders 
undergoing non-urgent hospitalization.
Results: Patients with lower values of Minimal Nutritional Assessment score had lower blood leptin con-
centration and lower value of leptin to CRP ratio. Compared to patients with leptin concentration in the 
upper quartiles, individuals in the lowest quartile had a lower BMI and fat mass, thinner skinfolds, greater 
skeletal muscle mass and handgrip strength. In comparison with the values for leptin-to-CRP ratio, albumin, 
albumin-to-CRP ratio and lymphocyte count, leptin explained a greater part of the variance in the majority 
of parameters of nutritional status and body composition. Contrasting associations of leptin with ideal 
(negative) and current (positive) body mass were found.  
Conclusions: Leptin was associated with parameters of nutritional status assessments more strongly 
than other biochemical parameters usually used. However, the use of leptin as a biomarker of nutritional 
status should be approached carefully and needs further evaluation, especially in the context of its strong 
association with both current and ideal body mass, the importance of receptors’ resistance to leptin, and 
leptin’s negative relationships with muscle mass and strength. 
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Introduction
Body composition is an important prognostic bio-
marker for inpatients [1]. It concerns patients’ nutritional 
status, metabolic rate and cardio-metabolic risk. We 
now have a number of indices of nutritional risk and 
status assessment [2–3], the majority of which concern 
patients’ malnutrition. However, obesity is also recog-
nized as an important contributor to many metabolic dis-
orders, including diabetes mellitus, hypertension, and 
dyslipidemia [4–6]. Obesity is also linked with the risk of 
functional impairment, cardiovascular event, in-hospital 
death, perioperative complications and prolongation of 
in-hospital stay [7–9]. The essence of obesity is exces-
sive adipose tissue accumulation. However, adipose 
tissue not only plays a role in energy storage, but is 
also the source of the majority of substances, called 
adipocytokines, which regulate many of the process-
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es in both the endocrine and paracrine pathways [5]. 
One such substance is leptin. Leptin takes part in the 
long-term regulation of energy intake, and decreases 
appetite level in relation to energy storage (it is known 
as the satiety hormone) through the central inhibition 
of the secretion of orexigenic substances. Moreover, 
leptin induces activation of peripheral sympathetic 
nerve activity, leading to increased energy expenditure; 
it restores and regulates hypothalamic neuroendocrine 
axes, including the thyroid, gonadal, adrenocortico-
tropic hormone (ACTH)-cortisol and growth hormone 
axes [6, 10]; plays a role in muscle-bone crosstalk 
[11], the central regulation of physical activity [12], 
age-related fat accumulation in muscles [13], and 
neurocognitive processes, emotions, and memory 
[6]; affects some of the pathophysiological processes 
in the cardiovascular system, such as the promotion 
of left ventricular hypertrophy, vascular remodeling, 
hypertrophy, angiogenesis, and the proliferation of 
neointimal and vascular smooth muscle cells; takes part 
in atherosclerosis processes [5, 7]; and is recognized as 
a mediator inducing the survival, proliferation, invasion, 
migration, angiogenesis and anti-apoptosis of cancer 
cells, especially in patients with so-called obesity-re-
lated neoplasms (e.g. prostate, colorectal, and breast) 
[14]. The pathophysiological importance of leptin in the 
course of the aforementioned disorders is related not 
only to the level of adipose tissue accumulation, but 
also to dysfunction of adipocytes, which is becoming 
increasingly understood, especially in patients with 
obesity and/or metabolic syndrome [15]. 
As leptin is secreted by adipose tissue, it would 
seem to be a potential biomarker of patients’ nutritional 
status, especially at the level of energy storage. How-
ever, the clinical importance of leptin does not appear 
to have been fully identified. The aim of this study is 
to determine the relationships between blood leptin 
concentration and several nutritional risk and status 
assessment scores among inpatients admitted due to 
cardiovascular disorders. 
Material and Methods
Patients
The participants were 160 patients who required 
scheduled hospitalization in an internal medicine ward 
due to mild exacerbation of cardiovascular diseases 
(persistent atrial fibrillation, life-limiting intermittent clau-
dication, stable angina pectoris, and hypertension). The 
exclusion criteria were: history or clinical signs of inflam-
matory processes or neoplasm; significant decrease 
in body weight during the three months prior to the 
current hospitalization (i.e. quotient of [100% × (usual 
weight — actual weight) / usual body weight] being 
greater than 5%); history of disorders affecting food 
intake or absorption; disturbance in nutritional status as 
a cause of hospitalization; and lack of informed consent 
for participation in the study. 
During the first day of hospitalization, a medical his-
tory was obtained from each of the inpatients enrolled 
to the study and a physical examination performed, 
including assessment of anthropometric parameters of 
nutritional status. The inclusion and exclusion criteria 
were checked on the basis of these data. One year 
after the hospitalization during which the leptin blood 
concentration was determined, a follow-up call was 
made to all the patients or their family members, who 
were asked questions concerning survival, reason for 
admission if hospitalized, and current functional status. 
Biochemical determinations
The day after admission, blood samples were 
taken from the patients’ ulnar vein between 7 am and 
8 am while they were in a fasting state. The following 
biochemical determinations were performed in the 
hospital’s diagnostic laboratory using standard meth-
ods: blood morphology, low-density lipoprotein (LDL) 
cholesterol, triglycerides, glucose, albumin, C-reactive 
protein (CRP), absolute lymphocyte count, and thyro-
tropin-stimulating hormone (TSH). Laboratory deter-
minations were performed in the hospital’s diagnostic 
laboratory using standard methods. 
The blood samples for leptin determination were 
centrifuged at 4 °C and 3600 rev/min. The serum ob-
tained was stored at -80 °C until determination. Leptin 
determination was performed using an ELISA kit by 
ALPCO (cat. no 11-LEPHU-E01) in accordance with the 
manufacturer’s instructions. 
Scores of nutritional risk 
The following nutritional risk assessment surveys 
were performed: Nutritional Risk Screening-2002 (NRS-
2002) [2], Mini Nutritional Assessment (MNA) [16], and 
Geriatric Nutritional Risk Index (GNRI) [17, 18]. 
Parameters of nutritional status assessment
A nutritional status assessment was performed for all 
the study participants. The following parameters were 
measured: height (cm), body weight (kg), waist circum-
ference (WC, cm), hip circumference (HC, cm), mid-arm 
circumference (MAC, cm), mid-calf circumference (MCC, 
cm), triceps skinfold thickness (TSF, mm), biceps skinfold 
thickness (BSF, mm), subscapular skinfold thickness 
(SST, mm), abdominal (suprailiac) skinfold thickness 
(AST, mm), knee height (cm), as well as the handgrip 
strength of the predominant and non-predominant 
hands. All circumferences were measured using tape, 
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skinfolds using a Harpender MG-4800 skinfold clockwork 
caliper (produced by BATY, UK), and handgrip strength 
using an electronic dynamometer (manufactured by Kern, 
Germany). Body composition was determined using 
bioelectrical impedance analysis (BIA) and a TANITA BC 
420 MA device (TANITA Corporation, Tokyo, Japan). The 
following parameters were analyzed: fat mass (FM; % 
and kg), visceral fat level (ranged 1–59, level > 26 shows 
on abdominal fat distribution), fat-free mass (FFM, kg), 
predicted muscle mass (PMM, kg), skeletal muscle mass 
(%), bone mass (BM, kg), total body water (TBW, %, kg), 
body mass index (BMI, kg/m2), basal metabolic rate 
(BMR, kcal), and metabolic age (MA, years). 
The following secondary parameters were calculat-
ed based on the above-mentioned indices [2–3]: 
 — an “ideal weight” was calculated according to 
the Lorentz formula: for female patients, ide-
al weight = [height (cm) — 100] — {[height 
(cm) — 150]/2}; and for male patients, ideal 
weight = [height (cm) — 100] — {[height (cm) 
— 150]/4} [18];
 — absolute (actual [current] — ideal body weight) and 
proportional (100% × [actual — ideal body weight] 
/ actual body mass) differences between actual and 
ideal body weight (excess of body mass); 
 — the quotient of actual (current) to ideal body 
mass × 100%;
 — GNRI according to the following formula [18]: 
GNRI = 1.519 × blood albumin concentra-
tion + 41.7 × actual body mass (current weight) 
/ideal body mass [18–19];
 — mid-arm muscle circumference (MMC) according 
to the following formula: MMC = MAC – π × TSF 
(in this study, a value of 3.14 was substituted for π);
 — arm muscle area (AMA) according to the following 
formula: AMA = {[MAC- (0.314×TSF)]2 / (4π); 
 — arm fat area (AFA) according to the following formula: 
AFA = (MAC2/4π) — [(MAC -(0.314×TSF)]2 / (4π); 
 — brachial adipo-muscular ratio (BAMR) according to 
the following formula: BAMR = AFA / AMA; 
 — blood-leptin-to-CRP ratio;
 — blood-albumin-to-CRP ratio; 
 — blood albumin in one of the following rang-
es: < 2.5 g/l; 2.5–3.0 g/l; 3.0–3.5 g/l; ≥ 3.5 g/l; 
 — b lood lymphocy te  count  in  the  fo l low-
ing ranges: < 800 G/l; 800–1200 G/l; 1200–
1500 G/l; > 1500 G/l; 
 — the difference between actual (metric) and metabolic 
age determined using BIA. 
Bioethics
The investigation was conducted in compliance with 
the Declaration of Helsinki for medical research, after 
receiving permission from local Bioethical Committee 
No. 389/2015. Each patient gave written consent to 
participating in the study. 
Statistics
Statistical analysis was conducted using licensed 
versions of statistical software STATISTICA (a data 
analysis software system), StatSoft, Inc. (2015), version 
12. The normal distribution of the study variables was 
checked using the Shapiro-Wilk test. The results were 
mainly presented as the mean ± standard deviation, or 
n, %. The statistical significance of differences between 
groups was verified using the Student’s t-test, U Man 
Whitney-test and Chi2 test. Pearson’s linear correla-
tions were determined. Stepwise backward multiple 
regression (using the General Regression Models 
module) was applied to check the relationships be-
tween the values of the blood leptin concentration and 
the demographic data, and parameters of nutritional 
status. Subjects’ age, gender, history of atrial fibrilla-
tion, diabetes mellitus, and chronic heart failure, as 
well as such parameters of nutritional status, as: MNA 
total score, actual and ideal body mass, percentage of 
fat mass, skeletal muscle mass, visceral fat level were 
selected as the independent variables. The statistical 
significance level was set at a p-value < 0.05. 
Results
Patients with MNA score in the lowest quartile 
(Q1; MNA score ≤ 23) had significantly lower blood 
leptin concentration than subjects in the second 
(Q2; < 23MNA score ≤ 25) MNA quartile (Q1 vs. Q2: 
34.64 ± 33.94 vs. 51.62 ± 37.82 pg/ml; p = 0.042). 
Moreover, compared to subjects with MNA score 
between 17 and 23 (n = 51), patients with MNA score 
greater or equal to 24 (n = 105) had significantly 
greater ratio of blood leptin and CRP concentrations 
(24.94 ± 26.63 vs. 14.04 ± 13.70 pg/ml; p = 0.009). 
Similarly, subjects with MNA score in Q1 had significant-
ly lower value of blood leptin to CRP ratio than subjects 
with MNA score in Q3 and Q4. 
On the other hand, compared to the other quartiles, 
patients with a blood leptin concentration in the lowest 
quartile had significantly lower actual body mass and 
BMI (Tab. 1), and thinner tricuspid, scapular and ab-
dominal skinfolds, and lower MAC and BAMR (data not 
presented). In relation to the third and fourth quartiles 
individuals from the lowest quartile of blood leptin 
concentration had significantly greater ideal body mass 
calculated in accordance with the Lorentz formula, and 
greater handgrip strength in the predominant hand. 
Compared to the other blood leptin quartiles, patients 
in the lowest quartile for blood leptin concentration also 
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had a lower excess body mass, lower fat mass and 
visceral fat level. Whereas, predicted muscle mass and 
skeletal muscle mass were greater in subjects in the 
lowest blood leptin concentration quartile compared to 
the uppermost quartile. Basal metabolic rate was the 
highest in the second quartile of leptin blood concentra-
tion. However, patients with a blood leptin concentration 
in the uppermost quartile compared to individuals with 
blood leptin concentration from the lower quartiles 
were significantly older and were less likely to be male 
(Tab. 2). Patients with blood leptin concentration in the 
lowest quartile had also a lower prevalence of diabetes 
mellitus, cardiac heart failure, chronic kidney disease, 
and atrial fibrillation than individuals with blood leptin 
concentration in uppermost quartile (Tab.2). 
We next calculated the linear correlations between 
blood concentrations of leptin, albumin, ratios of 
leptin-to-CRP and blood albumin-to-CRP, and blood 
lymphocyte count with the values of the scores of 
nutrition-related risk and anthropometric parameters 
analyzed for nutritional status assessment (Tab. 3). 
In comparison with the values of the leptin-to-CRP ratio, 
blood albumin concentration and blood lymphocyte 
count, the blood leptin concentration correlated signifi-
cantly with a greater number of the analyzed parameters 
of nutritional status assessment. Moreover, blood leptin 
concentration explained the greater part of the variance 
in the majority of the parameters of nutritional status, 
especially when they concerned fat mass, determined 
in anthropometric measurements (e.g. skinfolds), or 
using BIA. On the other hand, the blood leptin con-
centration had no statistically and clinically significant 
relationships with nutritional risk indices, such as the 
NRS-2002, and MNA. 
Taking into account the role of leptin in obesity 
pathogenesis (as the satiety hormone and an inductor of 
energy expenditure), we also analyzed the relationships 
between blood leptin concentration and ideal and actual 
body weight, basal metabolic rate (BMR) and metabolic 
age (Tab. 3). We found that blood leptin concentration 
was positively correlated with actual body weight (Fig.1) 
and fat mass, but negatively with ideal body mass 
(Tab. 3, Fig. 2). Moreover, blood leptin concentration 
was also strongly related to metabolic age but not to 
BMR. However, after adjustment in stepwise backward 
multiple regression multiple regression method only 
CHF, actual and ideal body mass, and visceral fat 
level remained significant determinant of blood leptin 
concentration (Tab. 4)
Neither the median value nor any of the quartile 
values of blood leptin concentration were statistically 
significantly associated with risk of all-cause mortal-
ity (nine patients died during the one-year follow-up, 
p = 0.429 and p = 0.337, respectively) and read-
mission (during the one-year follow-up, 29 patients 
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Correlation between blood leptin concentration 
and actual body weight r= 0.29; p < 0.001 
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Figure 1. Correlation between blood leptin concentration and actual body mass
Correlation between blood leptin concentration 
and ideal body mass r= –0.439; p < 0.001 
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Figure 2. Correlation between blood leptin concentration and ideal body mass
were readmitted due to any cause; p = 0.344 and 
p = 0.344, respectively) subsequent to the one-
year follow-up phone call (data not presented in 
detail). 
Discussion
In this study, performed among inpatients without 
significant weight loss during the three months prior to 
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Table 3. Leptin blood concentration correlation with nutritional risk and nutritional assessment parameters (n = 160)
Parameter Blood leptin 
concentration
Leptin-to-CRP 
ratio
Blood albumin 
concentration
Albumin-to-
CRP ratio
Blood 
lymphocyte 
count
Nutritional Risk Screening-2002 
(NRS-2002) score
ns ns R = –0.25; 
p = 0.001
R = –0.29; 
p < 0.001
ns
Mini Nutritional Assessment (MNA) 
score
ns R = 0.24; 
p = 0.003
R = 0.35; 
p < 0.001
R = 0.20; 
p = 0.01
ns
Geriatric Nutritional Risk Index 
(GNRI)
R = 0.64; 
p < 0.001
R = 0.18; 
p = 0.03
ns R = –0.21; 
p = 0.01
R = 0.24; 
p = 0.003
Age (years) R = 0.24; 
p = 0.002
ns ns R = –0.18; 
p = 0.026
ns
Male gender R = –0.53; 
p < 0.001
R = –0.27; 
p < 0.001
ns ns ns
Actual body weight (kg) R = 0.30; 
p <0.001
ns ns R = –0.16; 
p = 0.048
R = 0.19; 
p = 0.02
Ideal body mass (Lorentz formula, 
kg)
R = –0.44; 
p < 0.001
R = –0.22; 
p = 0.006
ns ns ns
Actual-to-ideal body mass ratio (%) R = 0.64; 
p < 0.001
R = 0.16; 
p = 0.046
ns R = –0.23; 
p = 0.003
R = 0.24; 
p = 0.002
Body mass index (BMI) (kg/m2) R = 0.60; 
p < 0.001
ns ns R = –0.22; 
p = 0.005
R = 0.21; 
p = 0.008
Waist circumference (WC, cm) R = 0.44; 
p < 0.001
ns ns R = –0.22; 
p = 0.005
ns
Handgrip strength of predominant 
hand (kg)
R = –0.41; 
p < 0.001
ns R = 0.17; 
p = 0.03
R = 0.17; 
p = 0.04
ns
Fat mass determined by BIA (FM, %) R = 0.74; 
p < 0.001
R = 0.35; 
p < 0.001
ns ns ns
Fat-free mass (FFM, kg) R = –0.23; 
p = 0.003
R = –0.22; 
p = 0.005
ns ns ns
Predicted muscle mass (PMM, kg) R = –0.24; 
p = 0.003
R = –0.22; 
p = 0.006
ns ns ns
Percentage of skeletal muscle mass 
(%)
R = –0.73; 
p < 0.001
R = –0.35; 
p < 0.001
ns ns ns
Level of visceral adipose tissue 
(score)
R = 0.25; 
p = 0.001
ns ns ns ns
Basal metabolic rate (by BIA, kcal) ns R = –0.17; 
p = 0.028
ns ns ns
Metabolic age (MA, years) R = 0.59; 
p < 0.001
R = 0.22; 
p = 0.005
ns R = –0.22; 
p = 0.005
R = 0.15; 
p = 0.057
Difference between metric and 
metabolic age (years)
R = 0.42; 
p < 0.001
R = 0.19; 
p = 0.02
ns ns R = 0.12; 
p = 0.014
Abbreviations: data are presented as R and p; BIA = bioelectrical impedance analysis; CRP = C-reactive protein; ns- non-significant statistically
non-urgent admission to hospital due to cardiovascular 
disorders, we confirmed data from the literature [4–6, 
15, 19] that an increase in blood leptin concentration 
is positively associated with higher age and female 
gender and the prevalence of metabolic disorders and 
cardiovascular disorders, such as diabetes mellitus, 
chronic heart failure and atrial fibrillation (Tab. 2). Blood 
leptin concentration was also statistically significantly 
associated with the majority of the parameters of nu-
tritional status assessments; however, its relation to 
scores of nutrition-related risk, such as NRS2002, MNA, 
and GNRI, had no clinical importance (Tab. 1, Tab. 3). 
A number of statistically significant correlations between 
blood leptin concentration and the parameters men-
tioned were found (Tab. 3); however, in multifactorial 
analysis only current and ideal body mass, visceral fat 
level and percentage of fat mass remained significant 
(Tab. 4). The values of the majority of the determina-
tion coefficients (R2) of these correlations were greater 
for leptin than for classic biochemical parameters of 
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Table 4. Stepwise backward multiple regression analysis for respective parameters determining blood leptin 
concentration; R2 = 0.81; adjusted R2 = 0.65; F = 59.45; p < 0.01
Independent variable b Standard
error for β
t p
Constant 1.11 0.27
CHF 0.21 0.05 4.33 < 0.001
Visceral fat level - 0.17 0.08 - 2.08 0.04
Body weight (kg) 0.34 0.09 3.70 < 0.001
Ideal body mass (kg) - 0.33 0.08 - 3.94 < 0.001
Fat mass (%) 0.55 0.08 6.84 < 0.001
nutritional status assessment, such as blood albumin 
concentration, albumin-to-CRP ratio and blood lympho-
cyte count (Tab. 3). Our observations also corroborate 
outcomes reported by other authors [4–6, 15, 19]. It is 
known that leptin is a hormone produced in adipose 
tissue and, therefore, correlations between blood leptin 
concentrations and biomarkers of fat mass (BMI, waist 
circumference, BIA, and skinfold thickness) are to be 
expected. However, lack of association between leptin 
and WHR may be surprising (Tab. 1, Tab. 3).  
In the authors’ opinion, the most interesting observa-
tions obtained in this study were the negative correlation 
of blood leptin concentration and ideal body mass (Fig. 2) 
and the positive correlation with actual body mass 
(Fig. 1), excess body weight and the values of a lot of 
the indices of adipose tissue accumulation investigat-
ed (Tab. 3, Tab. 4). Moreover, patients from first and 
second quartiles of blood leptin concentration had 
significantly higher ideal body mass and lower excess 
of body mass than their counterparts with blood leptin 
concentration in the third and fourth quartiles (Tab. 1). 
We suggest that the only explanation of such opposing 
relationships between ideal and current body weight is 
a maximal level of sensitivity to leptin, determined indi-
vidually (genetically and environmentally) and related to 
ideal body mass. In this context, negative associations 
between blood leptin concentration and excess current 
body mass (Tab. 1, Tab. 3, Tab. 4) correspond to leptin 
resistance described in patients with obesity [6, 10, 20]. 
To the best of our knowledge, this is the first such ob-
servation showing different relationships of blood leptin 
concentration to actual and ideal body mass. This may 
be of importance in explaining the not fully understood 
pathogenesis of overweight and obesity, especially as 
leptin is considered a potential tool for obesity therapy 
[6]. On the other hand, such therapy seems to have 
the potential to be effective in only a small number of 
patients with obesity and hypoleptinemia. 
What may be surprising are the negative correlations 
between blood leptin concentration and indices of 
muscle mass and muscle strength (Tab. 3). However, 
these observations corroborate a study by Gubelmann 
et al. [21], who found negative correlations between 
log-transformed leptin and grip strength in a popula-
tion-based sample in Lausanne. Bucci et al. [22] also 
suggested the contribution of age-related increases in 
fat mass and blood leptin concentration to age-associ-
ated physical inactivity, sarcopenia and loss of strength. 
In an investigation by Karvonen-Gutierrez et al. [8], 
higher baseline leptin concentrations predicted poorer 
mobility-based functioning, which is generally related 
to muscle mass. However, Rachakonda et al. [23] 
found a lower log-transformed leptin level in malnour-
ished inpatients with end-stage liver cirrhosis. In this 
work, malnutrition was diagnosed, i.a. on the basis of 
a mid-arm circumference of less than 23 cm, indicating 
sarcopenia. These results may have some impact on 
knowledge concerning muscle adipose tissue crosstalk 
[11], sarcopenic obesity [13, 24] and its organic com-
plications, especially concerning liver steatosis [25], 
patients’ functional status [1, 8], and obesity-related 
all-cause mortality [4, 26].
Although we found a number of statistically 
significant relationships between blood leptin 
concentration and parameters of nutritional status 
assessment (Tab. 2, Tab. 3, Fig. 1, Fig. 2), our ob-
servations should be interpreted with caution due to 
some limitations. Firstly, our study population was 
relatively small. Secondly, our study population did 
not consist of healthy people, but patients with stable 
cardiovascular disorders that only required sched-
uled hospitalization. Therefore, our results cannot be 
extrapolated to healthy individuals. Thirdly, patients’ 
physical activity was not taken into account. How-
ever, work by Guerra et al. [27] shows an increase 
in blood leptin concentration after one week of bed 
rest. Exercise habits also had an effect on muscle 
mass and handgrip strength, and leptin seems to 
take part in the central regulation of physical activity 
in a dopamine-dependent manner [12]. 
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conclusions
Leptin is associated with parameters of inpatients’ 
nutritional status assessments more strongly than 
other frequently used biochemical parameters, such 
as blood albumin concentration, albumin-to-CRP ratio 
and blood lymphocyte count. However, the use of blood 
leptin concentration determination as a biomarker of 
nutritional status should be approached carefully and 
needs further evaluation, especially in the context of 
its strong association with both current and ideal body 
mass, the importance of receptors’ resistance to leptin, 
and leptin’s negative relationships with muscle mass 
and strength. 
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